Bank Syariah Indonesia Tbk vs Kalbe Farma Tbk — how do they compare? Bank Syariah Indonesia Tbk trades at Rp1,730 (market cap 79.23T, 9.56M 24h volume), while Kalbe Farma Tbk trades at Rp705 (market cap 34.17T, 156.61M 24h volume). The key difference: Bank Syariah Indonesia Tbk is far larger — about 2.3× Kalbe Farma Tbk's market cap, and Kalbe Farma Tbk is more actively traded (156.61M versus 9.56M). Which is the better fit depends on your goals.
| BRIS | KLBF | |
|---|---|---|
Market Cap | 79.23T | 34.17T |
Volume | 9.56M | 156.61M |
Lot | 95.64K | 1.57M |
Turnover | 16.64B | 111.23B |
Average Price | 1,740 | 710.21 |
Value | 16.64B | 111.23B |
Indicative Equilibrium Price | 1,730 | 705 |
Indicative Equilibrium Volume | 9.17K | 56.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank BRISyariah Tbk (the Bank) is located in Jakarta, Indonesia, and initially established under the name of PT Bank Jasa Arta (BJA) based on the Deed of Establishment No. 4 dated April 3, 1969 of Liem Toeng Kie, S.H., Notary in Jakarta.
Read more on BRIS →PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →